Current status of amyloid-targeting immunotherapies for Alzheimer's disease

被引：9
|
作者：
Tabor, G. Travis [1 ,2 ,3 ]
Holtzman, David M. [1 ,2 ]
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA
[3] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO USA
来源：
SCIENCE TRANSLATIONAL MEDICINE | 2023年 / 15卷 / 721期
关键词：
D O I：
10.1126/scitranslmed.adk9993
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Anti-amyloid antibodies are moving from clinical trials into patients to treat early clinical stages of Alzheimer's disease. Anti-amyloid antibodies are moving from clinical trials into patients to treat early clinical stages of Alzheimer's disease.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Modified Immunotherapies Against Alzheimer's Disease: Toward Safer and Effective Amyloid-β Clearance
    Wang, Yan-Jiang
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1065 - 1075
  • [42] Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
    Martin Tolar
    Susan Abushakra
    John A. Hey
    Anton Porsteinsson
    Marwan Sabbagh
    Alzheimer's Research & Therapy, 12
  • [43] Targeting Brain α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Rationale and Current Status
    Ana Sofía Vallés
    María Virginia Borroni
    Francisco J. Barrantes
    CNS Drugs, 2014, 28 : 975 - 987
  • [44] Targeting Brain α7 Nicotinic Acetylcholine Receptors in Alzheimer's Disease: Rationale and Current Status
    Sofia Valles, Ana
    Virginia Borroni, Maria
    Barrantes, Francisco J.
    CNS DRUGS, 2014, 28 (11) : 975 - 987
  • [45] Immunotherapies for Alzheimer's Disease-A Review
    Valiukas, Zachary
    Ephraim, Ramya
    Tangalakis, Kathy
    Davidson, Majid
    Apostolopoulos, Vasso
    Feehan, Jack
    VACCINES, 2022, 10 (09)
  • [46] Immobilized Amyloid Hexamer Fragments to Map Active Sites of Amyloid-Targeting Chemicals
    Cho, Illhwan
    Yoon, Soljee
    Park, Sunghyun
    Hong, Seung Woo
    Cho, Eunjung
    Kim, Eosu
    Kim, Hye Yun
    Kim, YoungSoo
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (01): : 9 - 18
  • [47] Targeting the amyloid-β peptide for the treatment of Alzheimer's disease -: Preface
    Tsai, JY
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (11)
  • [48] Targeting SPII to mitigate amyloid-β pathology in Alzheimer's disease
    Shao, Jie
    Youngblood, Hannah
    Yang, Luodan
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 104 (02) : 334 - 337
  • [49] Immunotherapies: A Treasure Trove of Alzheimer's Disease
    Kolay, Ankit
    Singh, Neelam
    Gupta, Puneet
    Shaikh, Ayaz Mukarram
    Goel, Radha
    Nagpal, Dheeraj
    Chitme, Havagiray
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [50] TARGETING AMYLOID PRECURSOR PROTEIN SECRETASES: ALZHEIMER'S DISEASE AND BEYOND
    Ganjei, J. Kelly
    DRUG NEWS & PERSPECTIVES, 2010, 23 (09) : 573 - 584
12345